Oruka Therapeutics (ORKA) Enterprise Value: 4.983B

Oruka Therapeutics, Inc. (ORKA)

95.23 -0.58 (-0.61%) USD | NASDAQ | Oct 28, 13:12

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1999. Start Trial.

Date	Value
October 27, 2026	4.983B
October 26, 2026	4.648B
October 23, 2026	4.027B
October 22, 2026	4.088B
October 21, 2026	4.013B
October 20, 2026	3.962B
October 19, 2026	3.680B
October 16, 2026	3.525B
October 15, 2026	3.643B
October 14, 2026	3.815B
October 13, 2026	3.907B
October 12, 2026	4.039B
October 09, 2026	4.146B
October 08, 2026	3.851B
October 07, 2026	3.987B
October 06, 2026	4.028B
October 05, 2026	4.285B
October 02, 2026	4.294B
October 01, 2026	4.226B
September 30, 2026	4.218B
September 29, 2026	4.149B
September 28, 2026	4.273B
September 25, 2026	4.290B
September 24, 2026	4.353B
September 23, 2026	4.624B

Date	Value
September 22, 2026	4.906B
September 21, 2026	4.835B
September 18, 2026	4.931B
September 17, 2026	5.100B
September 16, 2026	4.845B
September 15, 2026	4.763B
September 14, 2026	4.990B
September 11, 2026	4.774B
September 10, 2026	4.729B
September 09, 2026	4.720B
September 08, 2026	4.891B
September 04, 2026	4.781B
September 03, 2026	4.689B
September 02, 2026	4.728B
September 01, 2026	4.757B
August 31, 2026	4.788B
August 28, 2026	4.698B
August 27, 2026	5.028B
August 26, 2026	5.205B
August 25, 2026	5.350B
August 24, 2026	5.387B
August 21, 2026	5.725B
August 20, 2026	5.536B
August 19, 2026	5.831B
August 18, 2026	6.038B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks